Search results
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
InvestorPlace· 10 hours agoWith biotech stocks enjoying a permanently relevant narrative, investors should focus on these...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 9 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 13 hours agoMustang Bio (NASDAQ:MBIO) stock is taking off on Monday after the clinical-stage biopharmaceutical company announced positive results from a study. The...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 9 hours agoWedbush analyst Laura Chico slashed her price target on Aerovatestock to 3 from 41, calling the...
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
InvestorPlace· 4 days agoFundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means...
131,490 Shares in Fortress Biotech, Inc. (NASDAQ:FBIO) Acquired by PVG Asset Management Corp
ETF DAILY NEWS· 16 hours agoPVG Asset Management Corp acquired a new position in shares of Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) during the 4th quarter, according to the company in its most ...
7 A-Rated Biotech Stocks Worth Betting On in June
InvestorPlace· 4 days agoLet me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance.
Krystal Biotech Stock Sees RS Rating Jump To 91
Investor's Business Daily· 6 days agoOn Tuesday, Krystal Biotech stock cleared an important technical benchmark, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile...
Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $42.45
ETF DAILY NEWS· 17 hours agoLegend Biotech Co. (NASDAQ:LEGN – Get Free Report) shares gapped up prior to trading on Monday . Legend Biotech shares last traded at $42.20, with a volume ...
NKGen Biotech (NYSE:NKGN) Trading Up 2.3%
ETF DAILY NEWS· 3 days agoNKGen Biotech, Inc. (NYSE:NKGN – Get Free Report) was up 2.3% during mid-day trading on Friday . The company traded as high as $1.36 and last traded at $1.35. Approximately ...
